EUVIMEDEUVIMED entdecken
Crossref

Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification

Yuxuan Chen, Shiyu Chen, Kaiju He, Xiang Zhao, Yue Yang, Yidi Zhu, Xiangsong Wu

European Journal of Surgical Oncology · 2026-09 · 52 (9) · 112031

DOI: 10.1016/j.ejso.2026.112031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-09. Verfasst von Yuxuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Labora…. Hauptthemen laut MEDLINE: Gallbladder Neoplasms. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: In the AJCC 8th edition, N2M0 and M1 gallbladder cancer (GBC) are classified into Stage IVB, leading clinicians to treat them identically. This study separates N2M0 from M1 disease, re-evaluating chemotherapy, surgical quality, and establishing a clinical risk stratification system (CRSS). MATERIALS AND METHODS: Stage IVB GBC patients (2000-2022) were identified from the SEER database. A 1:3 propensity score matching (PSM) balanced N2M0 and M1 baseline characteristics. Overall survival was compared, optimal lymph node ratio (LNR) was identified, and the prediction model internally verified using 1000 bootstrap resamples. RESULTS: From 7270 initial IVB patients, PSM matched 125 N2M0 and 343 M1 patients. N2M0 patients demonstrated superior median overall survival versus M1 patients (17 vs. 9 months, P = 0.001). However, this survival advantage depended entirely on adjuvant chemotherapy. Untreated N2M0 patients had a worse prognosis than treated M1 patients (P = 0.002). For N2M0 patients, extended multi-organ resection offered no survival benefit over standard radical cholecystectomy (HR = 0.724, P = 0.225). A lower LNR (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsHumansNeoplasm StagingFemaleChemotherapy, AdjuvantRisk AssessmentMaleAgedMiddle AgedCholecystectomySurvival RateSEER ProgramPropensity ScoreLymph Node ExcisionLymph Node RatioLymphatic MetastasisPrognosisLymph Nodes

Stichwörter der Autor:innen

Adjuvant chemotherapyGallbladder cancerN2M0Risk stratificationSurgical de-escalation

Autor:innen und Institutionen

  • Department of General Surgery, Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
  • Department of General Surgery, Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China. Electronic ad…

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission

Zitieren

APA

Chen, Y., Chen, S., He, K., Zhao, X., Yang, Y., Zhu, Y., & Wu, X. (2026). Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification. European Journal of Surgical Oncology, 52(9), 112031. https://doi.org/10.1016/j.ejso.2026.112031

Vancouver

Chen Y, Chen S, He K, Zhao X, Yang Y, Zhu Y, et al. Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification. European Journal of Surgical Oncology. 2026;52(9):112031. doi:10.1016/j.ejso.2026.112031

BibTeX
@article{Chen2026,
  author = {Chen, Yuxuan and Chen, Shiyu and He, Kaiju and Zhao, Xiang and Yang, Yue and Zhu, Yidi and Wu, Xiangsong},
  title = {Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {9},
  pages = {112031},
  doi = {10.1016/j.ejso.2026.112031}
}
Kostenlos starten →